The Peptide-Builder is designed for peptide chemists who want to make high-quality peptides quickly and easily at a laboratory scale. Peptides are synthesized sequentially and fully automated either ...
MINNEAPOLIS & TORRANCE, Calif.--(BUSINESS WIRE)--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and PolyPeptide ...
Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and ...
Chromatography industry faces AI adoption challenges, workforce issues, and budget constraints, with biopharmaceutical sectors showing career growth. Peptide science is revolutionized by GLP-1 drugs, ...
From bench to bulk, pharmaceutical customers will benefit from the latest solvent innovations and technologies in addition to an expanded portfolio with the Tedia partnership DOWNERS GROVE, Ill., May ...
1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced the publication of PEGASUS (TM), a multimodal AI model that achieves state-of-the-art ...
The new system, which produces the same high-quality peptides as Vapourtec’s existing Peptide-Explorer, launched in 2020, features a more compact footprint and is available at a lower price point.
There has been a recent revival in interest in peptide therapeutic development, with five of the top-selling drugs being peptides or proteins (Enbrel, Remicade, Humira, Avastin, MabThera) and many ...
The collaboration between Donaldson and PolyPeptide marks a milestone in the pharmaceutical industry's pursuit of environmentally friendly manufacturing practices. By leveraging Donaldson's experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback